Allervax Ragweed peptide immunotherapy: Began Phase II trials in 150 allergic patients, using nasal, conjunctival, and bronchial challenge. The bronchial challe

ImmuLogic Pharmaceutical Corp. (IMUL), Waltham, Mass. Product: Allervax Ragweed peptide immunotherapy Indication: Ragweed allergy Status: Began Phase II trials in 150 allergic patients, using nasal, ...